Prospective, multicenter, open-label study to evaluate the efficacy of esmolol in the early identification of cardiovascular disorders induced by cirrhosis, diabetes mellitus and cardiotoxic treatments (bB-ECHO).

Project information

To study the efficacy of esmolol in the early identification of cardiovascular alterations induced by cirrhosis, diabetes mellitus, and cardiotoxic treatments.

Esmolol is a drug used in routine medical practice for the treatment of cardiac arrhythmias or in serious situations where it is necessary to rapidly control arterial hypertension.

• Reference: bB-ECHO
• Start date: January 1, 2021
• End date: December 31, 2024
• Funder: Instituto de Salud Carlos III
• Nature of project: National